|Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer|
B Fisher, S Anderson, J Bryant, RG Margolese, M Deutsch, ER Fisher, ...
New England Journal of Medicine 347 (16), 1233-1241, 2002
|Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation|
B Fisher, JH Jeong, S Anderson, J Bryant, ER Fisher, N Wolmark
New England Journal of Medicine 347 (8), 567-575, 2002
|Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2–positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG …|
EA Perez, EH Romond, VJ Suman, JH Jeong, G Sledge, CE Geyer Jr, ...
Journal of clinical oncology 32 (33), 3744, 2014
|Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2–positive breast cancer: joint analysis of data from NCCTG …|
EA Perez, EH Romond, VJ Suman, JH Jeong, NE Davidson, CE Geyer Jr, ...
Journal of clinical oncology 29 (25), 3366, 2011
|Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus …|
EH Romond, JH Jeong, P Rastogi, SM Swain, CE Geyer Jr, MS Ewer, ...
Journal of Clinical Oncology 30 (31), 3792, 2012
|Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast …|
IL Wapnir, SJ Anderson, EP Mamounas, CE Geyer Jr, JH Jeong, ...
Journal of Clinical Oncology 24 (13), 2028-2037, 2006
|Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and …|
SJ Anderson, I Wapnir, JJ Dignam, B Fisher, EP Mamounas, JH Jeong, ...
Journal of Clinical Oncology 27 (15), 2466, 2009
|Overexpression of Glut‐1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma|
M Kunkel, TE Reichert, P Benz, HA Lehr, JH Jeong, S Wieand, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2003
|Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy …|
A Taghian, JH Jeong, E Mamounas, S Anderson, J Bryant, M Deutsch, ...
Journal of Clinical Oncology 22 (21), 4247-4254, 2004
|Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project …|
EP Mamounas, JH Jeong, DL Wickerham, RE Smith, PA Ganz, SR Land, ...
Journal of Clinical Oncology 26 (12), 1965-1971, 2008
|Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials|
B Fisher, JH Jeong, J Bryant, S Anderson, J Dignam, ER Fisher, ...
The Lancet 364 (9437), 858-868, 2004
|Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer|
SM Swain, JH Jeong, CE Geyer Jr, JP Costantino, ER Pajon, ...
New England Journal of Medicine 362 (22), 2053-2065, 2010
|Updated results of the combined analysis of NCCTG N9831 and NSABP B-31 adjuvant chemotherapy with/without trastuzumab in patients with HER2-positive breast cancer|
EA Perez, EH Romond, VJ Suman, J Jeong, NE Davidson, CE Geyer, ...
Journal of clinical oncology 25 (18_suppl), 512-512, 2007
|Anthracyclines in early breast cancer: The abc trials—usor 06-090, nsabp b-46-i/usor 07132, and nsabp b-49 (nrg oncology)|
JL Blum, PJ Flynn, G Yothers, L Asmar, CE Geyer Jr, SA Jacobs, ...
Journal of clinical oncology 35 (23), 2647, 2017
|Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer|
B Fisher, JH Jeong, J Dignam, S Anderson, E Mamounas, DL Wickerham, ...
JNCI Monographs 2001 (30), 62-66, 2001
|Population-based study of competing mortality in head and neck cancer|
BS Rose, JH Jeong, SK Nath, SM Lu, LK Mell
Journal of clinical oncology 29 (26), 3503-3509, 2011
|Breast cancer adjuvant therapy: time to consider its time-dependent effects|
I Jatoi, WF Anderson, JH Jeong, CK Redmond
Journal of clinical oncology 29 (17), 2301, 2011
|Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and …|
AG Taghian, JH Jeong, EP Mamounas, DS Parda, M Deutsch, ...
Journal of clinical oncology 24 (24), 3927-3932, 2006
|Parametric regression on cumulative incidence function|
JH Jeong, JP Fine
Biostatistics 8 (2), 184-196, 2007
|Five year update of cardiac dysfunction on NSABP B-31, a randomized trial of sequential doxorubicin/cyclophosphamide (AC)→ paclitaxel (T) vs. AC→ T with trastuzumab (H)|
P Rastogi, J Jeong, CE Geyer, JP Costantino, EH Romond, MS Ewer, ...
Journal of Clinical Oncology 25 (18_suppl), LBA513-LBA513, 2007